Supira Medical Stock
Supira Medical is developing a next-generation percutaneous ventricular assist device .
Sign up today and learn more about Supira Medical Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Supira Medical Stock
Their model is a paradigm shift for the industry. Their incubator offers a centralized team and dedicated state-of-the-art facility creating a highly productive work environment with increased ideation, concept cross-pollination, concurrent work paths, faster decision-making and ultimately, superior products.
Funding History
| April 2018 | $15.5M |
|---|
Management
CEO
Jean Orth
Press
prnewswire - Feb, 12 2024
SUPIRA MEDICAL, INC., A SHIFAMED PORTFOLIO COMPANY, RECEIVES FDA BREAKTHROUGH DEVICE ...massdevice - Jan, 26 2024
Shifamed's Akura Medical raises $35M for thrombectomy systemmassdevice - Dec, 22 2023
Shifamed's Adona Medical unveils next-gen heart failure ...finsmes - Nov, 22 2023
Supira Medical Closes $40M In Series D Financingfinsmes - Mar, 1 2022
Supira Medical Closes $30M Series C FundingEquityZen Recognized As:
